sábado, 13 de febrero de 2021

Four potential COVID-19 therapeutics enter Phase 2/3 testing in NIH ACTIV-2 trial | National Institutes of Health (NIH)

Four potential COVID-19 therapeutics enter Phase 2/3 testing in NIH ACTIV-2 trial | National Institutes of Health (NIH)

No hay comentarios:

Publicar un comentario